A 60-year-old diabetic male patient with chronic kidney disease on haemodialysis was hospitalised for sepsis due to methicillin-susceptible Staphylococcus aureus bacteraemia. He presented back pain and fever. Piperacillin/tazobactam and vancomycin were initiated and a chest-abdomen-pelvis computed tomography (CT) was requested to detect infectious foci.
Contrast-enhanced chest-abdomen-pelvis CT scan revealed a focal, saccular dilatation in the aortic arch, with perianeurysmal fluid-density collection and fat stranding (Fig. 1). Vertebral spondylodiscitis in D10 and D11 vertebral bodies was also present.
Blood tests revealed mild anaemia (haemoglobin levels: 12 g/dL; reference value 13-17,5 g/dL), leukocytosis (leukocyte levels: 13,96 x 109/L; reference value 4-11 x 109/L), and elevated C-reactive protein (33 mg/dL; reference value <0,5 mg/dL).
The patient was maintained on antibiotics and the CT scan was repeated two weeks later. The scan revealed an increase in pseudoaneurysm size, with a multilobulated appearance (Fig. 2). Perianeurysmal fluid-density collection and fat stranding were also present. Septic arthritis of the left coxofemoral joint was also diagnosed on magnetic resonance.
One week later, he repeated the CT scan and the pseudoaneurysm was stable. Some hours later, the patient had a sudden cardiac arrest and did not respond to advanced life support resuscitation manoeuvres.
An infected or mycotic aneurysm results from an infectious process involving the arterial wall. The aorta is the most commonly affected artery [1-3]. Mycotic aortic aneurysm (MAA) is an uncommon condition, associated with significant morbidity and mortality [2,4,5].
Infected aneurysms can result from: infection of a pre-existing intimal defect by circulating infectious agent; haematogenous spread of infectious microemboli into vasa vasorum of a normally-sized artery or a pre-existing aneurysm; contiguous involvement of a vessel from an adjacent source of sepsis; or direct infectious inoculation of a vessel wall during vascular trauma [1,6]. The infectious arteritis causes arterial wall destruction with contained rupture and formation of a pseudoaneurysm. Staphylococcus, Streptococcus and Salmonella species are amongst the most common pathogens of MAA [1,4,7,8]. Predisposing factors include intravenous drug abuse, depressed immunity, diabetes mellitus, endocarditis, and septicaemia [2,4,7,9].
MAA diagnosis is often delayed, owing to the protean manifestations. Patients can present with fever and abdominal, back, or thoracic pain, depending on the location of the aneurysm [4,10], although some may be asymptomatic. Blood tests can show leukocytosis, elevated C-reactive protein, and positive blood cultures [4,10,11]. In addition to the clinical evidence of infection, the presence of suspicious imaging findings on CT or magnetic resonance angiography  may lead to MAA diagnosis.
Imaging is necessary to diagnose and characterise the infected aneurysms, to identify complications, to map the relevant vascular anatomy for treatment planning, and to assess treatment efficacy. CT angiography is the imaging method of choice.
Early changes of aortitis preceding MAA formation at CT include irregular arterial wall, periaortic fat stranding or hypoattenuating concentric rim, periaortic soft-tissue mass and periaortic gas .
On CT, MAA appears as a focal, contrast-enhancing aortic dilatation that is usually saccular, which can be multilobulated and may present rapid expansion [1,12-14], as was the case in our patient. Disrupted intimal calcifications may also be seen . Furthermore, perianeurysmal mass, stranding, fluid, gas and/or haematoma, and osteomyelitis in adjacent vertebral bodies may occur [12-15]. The vertebral spondylodiscitis and the septic arthritis of the left hip joint that our patient presented were probably other infectious foci.
MAA is associated with a poor prognosis because it tends to grow rapidly and rupture; besides, patients with MAA often have severe comorbidities, are immunosuppressed, and have co-existing sepsis .
Treatment options for MAA include antibiotic therapy alone or in combination with surgical and/or endovascular therapy [16,17].
Written patient consent for this case was waived by the Editorial Board. Patient data may have been modified to ensure patient anonymity.
 Lee WK, Mossop PJ, Little AF, Fitt GJ, Vrazas JI, Hoang JK, et al (2008) Infected (Mycotic) Aneurysms: Spectrum of Imaging Appearances and Management. Radiographics; 28:1853–68. (PMID: 19001644)
 Kaufman SL, White RI Jr, Harrington DP, Barth KH, Siegelman SS (1978) Protean manifestations of mycotic aneurysms. AJR Am J Roentgenol; 131:1019–25. (PMID: 104565)
 McCready RA, Bryant MA, Divelbiss JL, Chess BA, Chitwood RW, Paget DS (2006) Arterial infections in the new millennium: an old problem revisited. Ann Vasc Surg; 20:590–5. (PMID: 17039259)
 Oderich GS, Panneton JM, Bower TC, Cherry KJ Jr, Rowland CM, Noel AA, et al (2001) Infected aortic aneurysms: aggressive presentation, complicated early outcome, but durable results. J Vasc Surg; 34:900-8. (PMID: 11700493)
 Hsu RB, Chen RJ, Wang SS, Chu SH (2004) Infected aortic aneurysms: clinical outcome and risk factor analysis. J Vasc Surg; 40:30-5. (PMID: 15218459)
 Nakata Y, Shionoya S, Kamiya K (1968) Pathogenesis of mycotic aneurysm. Angiology; 19:593–601. (PMID: 5695978)
 Miller DV, Oderich GS, Aubry MC, Panneton JM, Edwards WD (2004) Surgical pathology of infected aneurysms of the descending thoracic and abdominal aorta: clinicopathologic correlations in 29 cases (1976 to 1999). Hum Pathol; 35:1112–20. (PMID: 15343514)
 Cinà CS, Arena GO, Fiture AO, Clase CM, Doobay B (2001) Ruptured mycotic thoracoabdominal aortic aneurysms: a report of three cases and a systematic review. J Vasc Surg; 33:861-7. (PMID: 11296343)
 Tsao JW, Marder SR, Goldstone J, Bloom AI (2002) Presentation, diagnosis, and management of arterial mycotic pseudoaneurysms in injection drug users. Ann Vasc Surg; 16:652–62. (PMID: 12203000)
 Müller BT, Wegener OR, Grabitz K, Pillny M, Thomas L, Sandmann W (2001) Mycotic aneurysms of the thoracic and abdominal aorta and iliac arteries: experience with anatomic and extraanatomic repair in 33 cases. J Vasc Surg; 33:106-13. (PMID: 11137930)
 Ishizaka N, Sohmiya K, Miyamura M, Umeda T, Tsuji M, Katsumata T, et al (2012) Infected aortic aneurysm and inflammatory aortic aneurysm-In search of an optimal differential diagnosis.J Cardiol.; 59:123-31. (PMID: 22218322)
 Macedo TA, Stanson AW, Oderich GS, Johnson CM, Panneton JM, Tie ML (2004) Infected aortic aneurysms: imaging findings. Radiology;231: 250–7 (PMID: 15068950)
 Sörelius K, di Summa PG (2018) On the Diagnosis of Mycotic Aortic Aneurysms. Clin Med Insights Cardiol.; 12:1179546818759678. (PMID: 29497343)
 Vogelzang RL, Sohaey R (1988) Infected aortic aneurysms: CT appearance. J Comput Assist Tomogr; 12:109-12. (PMID: 3335648)
 Soravia-Dunand VA, Loo VG, Salit IE (1999) Aortitis Due to Salmonella: Report of 10 Cases and Comprehensive Review of the Literature. Clin Infect Dis.; 29:862-8. (PMID: 10589904)
 Sörelius K, Mani K, Björck M, Sedivy P, Wahlgren CM, Taylor P, et al (2014). Endovascular treatment of mycotic aortic aneurysms: A European multicenter study. Circulation.; 130:2136-42. (PMID: 25378548)
 Aoki C, Fukuda W, Kondo N, Minakawa M, Taniguchi S, Daitoku K, et al (2017) Surgical Management of Mycotic Aortic Aneurysms. Ann Vasc Dis.; 10: 29–35. (PMID: 29034017)